Compare Hims and Hers Health Inc (HIMS) vs D Wave Quantum Inc (QBTS) Price & Performance

Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.

The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.

D-Wave Quantum (QBTS) trades at $16.73 with no change on the day, showing bearish technical signals despite a 100% analyst buy rating and $39.86 consensus price target. The company reported Q1 2026 EPS of -$0.05, beating expectations, but maintains deeply negative profitability metrics with a -2,957.23% net income margin. Recent news highlights CEO share sales and sector volatility, while the stock's 29% July decline reflects investor concerns about execution risks in the emerging quantum computing space.

QBTS offers substantial upside potential based on analyst targets but carries high risk due to significant losses, negative cash flow from operations, and speculative technology timeline. The dual-platform quantum strategy provides competitive differentiation, but investors face volatility from pre-commercialization phase challenges and dependence on future funding rounds to sustain operations.